| Literature DB >> 26954430 |
Karthikeyan Annamalai1, Karl-Heinz Gührs2, Rolf Koehler3, Matthias Schmidt1, Henri Michel1, Cornelia Loos1, Patricia M Gaffney4, Christina J Sigurdson4, Ute Hegenbart5, Stefan Schönland5, Marcus Fändrich6.
Abstract
Polymorphism is a wide-spread feature of amyloid-like fibrils formed in vitro, but it has so far remained unclear whether the fibrils formed within a patient are also affected by this phenomenon. In this study we show that the amyloid fibrils within a diseased individual can vary considerably in their three-dimensional architecture. We demonstrate this heterogeneity with amyloid fibrils deposited within different organs, formed from sequentially non-homologous polypeptide chains and affecting human or animals. Irrespective of amyloid type or source, we found in vivo fibrils to be polymorphic. These data imply that the chemical principles of fibril assembly that lead to such polymorphism are fundamentally conserved in vivo and in vitro.Entities:
Keywords: Alzheimer's disease; Parkinson's disease; prions; protein folding; systemic amyloidosis
Mesh:
Substances:
Year: 2016 PMID: 26954430 PMCID: PMC4864496 DOI: 10.1002/anie.201511524
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336